Cite
HARVARD Citation
Guner, R. et al. (2021). Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir. Journal of infection and public health. 14 (3), pp. 365-370. [Online].